We report a case of extragenital bowenoid papulosis in a man with AIDS. The lesions occurred on the anterolateral aspects of the neck, and were not associated with clinical genitaJ or periungual involvement. In situ hybridization demonstrated abundant HPV DNA within the thirties group (31/33/35), in the absence of HPV-16 or -18.
on the neck. They initially developed unilaterally, but gradually encompassed both sides of the neck over a period of 12 months. He has been HIV"^ since 1985, and developed full-hlown AIDS in 1989. His current CD4 lymphocyte count is < 100 cells/mm'. AIDS-defming illnesses have included recurrent Pneumocystis carinii pneumonia, pneumococcal pneumonia, and disseminated Mycobacterium avium-intraceUulare infection. He gave a history of 'genital warts' many years ago, and these subsequently resolved. He could not recall the morphology of the lesions.
Physical examination revealed multiple, coalescing, red-brown, flat-topped verrucous papules, 5-lOmm in size, on the anterolateral aspects of the neck (Fig. 1) . Examination of the genital and perianal regions did not reveal any abnormality. He was cachectic, and had extensive seborrhoeic dermatitis of the scalp and face, and diffusely xerotic skin. Most of his fingernails exhibited yellow discoloration distally, but were otherwise normal. Histology of a biopsy of a papule within a verrucous plaque on the neck showed bowenoid changes consistent with BP (Fig. 2 ). There were no viral features.
In situ hybridization for human papillomavirus (HPV) DNA types 6/11, 16/18, and 31/33/35 was performed with three groups of probes, as directed by the manufacturer of the Viratype in situ hybridization kit (Digene Diagnostic, Gaithersburg, MD, U.S.A.), with minor modifications. In the prehybridization steps, the sections were pretreated with hydrochloric acid and proteinase K, followed by denaturation in 95% formamide at 65°C, as previously described.'^ The remainder of the procedure was as recommended by the manufacturer, with the exception that the hybridization was carried out overnight, and the slides were developed in the chromagenie substrate for 2 h rather than 1 h.
The results of in situ hybridization demonstrated high levels of HPV DNA of a type within the thirties group (31, 33, or 35). We did not have the probes to make an exact distinction. HPV-16 or -18 DNA was not detected (Figs 3a and b). The Omni probe assay was confirmatory. Positive and negative controls were also appropriate.
Clinical improvement has been achieved with periodic cryotherapy. patient. Unfortunately. HIV testing was not performed, and the patient was lost to follow-up.
Grob et al. suggested the possibility that their patient has used a contaminated razor, thereby accounting for the unusual distrihution of his lesions. The razor might have been used previously hy an HPV-infected sexual partner to remove pubic hair.^*^ There was no suggestion that this might have occurred in our patient, and he denied any recent sexual activity. He refused colposcopic examination of the anogenital region. Given his remote and nebulous history of genital 'warts', we cannot rule out suhclinical infection of these sites which, by autoinoculation. may have led to anterror neck involvement.
Suggested therapy for BP includes superficial surgery witb the CO2 laser, cryotherapy. electrodesiccation, and treatment with the neodymium: YAG ^*^^T opical retinoids. 5-fiuorouracil, and interferon-a, 0, and S can be effective.^^'^^ Despite initial therapeutic success, BP lesions, like condylomata, tend to recur.''^'* As far as we are aware, this is the first reported case of isolated extragenital HPV-thirties-group^ BP, and may be related to our patient's AIDS status. Isolated extragenital BP has been reported in a north African man of unknown HIV status who was HPy-lfi"^^" and, coincidentally. identical anatomical locations were involved in both patients. An HIV^ patient with genital BP was found to be HPV-33^, albeit weakly, hy in situ hybridization.^* but given the strong HPV-16 positivity in that patient, however, it is not known whether the signal for HPV-33 resulted from cross-hyhridization with HPV-16. in view of the known homology between them. Isolated extragenital BP may be an underreported phenomenon. Ideally, anogenital colposcopy should be performed to rule out subclinical genital infection. Evidence is accumulating that immunocompromised HIV^ patients represent a high-risk group for HPV-related anogenital cancer. ' ^" We are unaware of the progression of extragenital BP to carcinoma in any population or HPV subset. We recommend careful follow-up of HIV^ patients with chronic verrucous extragenital BP, and appropriate histological evaluation of changing or suspicious lesions.
